{
    "id": 11851,
    "fullName": "STK11 P281fs",
    "impact": "frameshift",
    "proteinEffect": "loss of function - predicted",
    "geneVariantDescriptions": [
        {
            "description": "STK11 P281fs likely results in a premature truncation of the Stk11 protein at amino acid 281 of 433 (UniProt.org). STK11 P281fs has not been characterized, however, due to the effects of truncation mutations downstream of P281 (PMID: 23612973), P281fs is predicted to lead to a loss of Stk11 protein function.",
            "references": [
                {
                    "id": 16023,
                    "pubMedId": 23612973,
                    "title": "Phosphorylation of serine 399 in LKB1 protein short form by protein kinase C\u03b6 is required for its nucleocytoplasmic transport and consequent AMP-activated protein kinase (AMPK) activation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23612973"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6794,
        "geneSymbol": "STK11",
        "terms": [
            "STK11",
            "hLKB1",
            "LKB1",
            "PJS"
        ]
    },
    "variant": "P281fs",
    "createDate": "09/15/2015",
    "updateDate": "08/21/2019",
    "referenceTranscriptCoordinates": {
        "id": 100581,
        "transcript": "NM_000455",
        "gDna": "chr19:g.1221320delC",
        "cDna": "c.842delC",
        "protein": "p.P281fs*6",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 19913,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MRTX849 and Pictilisib (GDC-0941) synergistically inhibited growth of a lung cancer cell line harboring KRAS G12C and STK11 P281fs in culture (PMID: 31658955).",
            "molecularProfile": {
                "id": 34655,
                "profileName": "KRAS G12C STK11 P281fs"
            },
            "therapy": {
                "id": 9252,
                "therapyName": "MRTX849 + Pictilisib",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16927,
                    "pubMedId": 31658955,
                    "title": "The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31658955"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 19888,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, MRTX849 and Afinitor (everolimus) synergistically inhibited viability of a lung cancer cell line harboring KRAS G12C and STK11 P281fs in culture, and induced tumor regression in a cell line xenograft model (PMID: 31658955).",
            "molecularProfile": {
                "id": 34655,
                "profileName": "KRAS G12C STK11 P281fs"
            },
            "therapy": {
                "id": 9000,
                "therapyName": "Everolimus + MRTX849",
                "synonyms": null
            },
            "indication": {
                "id": 1324,
                "name": "lung cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 16927,
                    "pubMedId": 31658955,
                    "title": "The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/31658955"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 11948,
            "profileName": "STK11 P281fs",
            "profileTreatmentApproaches": [
                {
                    "id": 8400,
                    "name": "mTORC1 Inhibitor",
                    "profileName": "STK11 P281fs"
                },
                {
                    "id": 8399,
                    "name": "mTOR Inhibitor",
                    "profileName": "STK11 P281fs"
                }
            ]
        },
        {
            "id": 34655,
            "profileName": "KRAS G12C STK11 P281fs",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 100581,
            "transcript": "NM_000455",
            "gDna": "chr19:g.1221320delC",
            "cDna": "c.842delC",
            "protein": "p.P281fs*6",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 100582,
            "transcript": "XM_005259617",
            "gDna": "chr19:g.1221320delC",
            "cDna": "c.842delC",
            "protein": "p.P281fs*6",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 100583,
            "transcript": "XM_005259618",
            "gDna": "chr19:g.1221320delC",
            "cDna": "c.842delC",
            "protein": "p.P281fs*6",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}